| Literature DB >> 36132493 |
Avijit Pramanik1, Dalephine Davis1, Shamily Patibandla1, Salma Begum1, Priyadarshini Ray1, Kaelin Gates1, Ye Gao1, Paresh Chandra Ray1.
Abstract
The emergence of antibiotic-resistant bacteria is the biggest threat to our society. The rapid discovery of drug resistant bacteria is very urgently needed to guide antibiotic treatment development. The current manuscript reports the design of a 2D-0D heterostructure-based surface enhanced Raman spectroscopy (SERS) platform, which has the capability for the rapid identification of the multidrug resistant strain of Salmonella DT104. Details of the synthesis and characterization of the heterostructure SERS platform using a two dimensional (2D) WS2 transition metal dichalcogenide (TMD) and zero dimensional (0D) plasmonic gold nanoparticles (GNPs) have been reported. The current manuscript reveals that the 2D-0D heterostructure-based SERS platform exhibits extremely high Raman enhancement capabilities. Using Rh-6G and 4-ATP probe molecules, we determined that the SERS sensitivity is in the range of ∼10-10 to 10-11 M, several orders of magnitude higher than 2D-TMD on its own (10-3 M) or 0D-GNPs on their own (∼10-6 to 10-7 M). Experimental and theoretical finite-difference time-domain (FDTD) simulation data indicate that the synergistic effect of an electromagnetic mechanism (EM) and a chemical mechanism (CM) on the heterostructure is responsible for the excellent SERS enhancement observed. Notably, the experimental data reported here show that the heterostructure-based SERS has the ability to separate a multidrug resistance strain from a normal strain of Salmonella by monitoring the antibiotic-pathogen interaction within 90 minutes, even at a concentration of 100 CFU mL-1. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 36132493 PMCID: PMC9417652 DOI: 10.1039/d0na00141d
Source DB: PubMed Journal: Nanoscale Adv ISSN: 2516-0230
Scheme 1(A) A schematic diagram showing the synthetic procedure we used for the development of 0D plasmonic gold nanoparticles. (B) A schematic diagram showing the synthetic procedure we used to develop 2D-WS2 nanosheets. (C) A schematic diagram showing the synthetic procedure we used to develop the 0D–2D heterostructure.
Fig. 1(A) A TEM image showing the morphology of the 0D-GNPs. (B) A TEM image showing the morphology of the heterostructure based on 2D-WS2 and 0D-GNPs, which indicates that the 0D-GNPs aggregate on 2D-WS2 (C) a SEM image showing the morphology of the heterostructure based on 2D-WS2 and 0D-GNPs. The inserted high resolution SEM image indicates that the 0D-GNPs aggregates on 2D-WS2. (D) The XRD spectrum from the heterostructure. (E) The Raman spectrum from the heterostructure. (F) Extinction spectra from the heterostructure, GNPs and WS2. (G) The EDX spectrum from the heterostructure.
Fig. 2(A) Plots showing how the Raman profile from 4-ATP varies in the presence of the 2D-WS2 surface and without any surface. To remove the Eg and A1g band contributions from WS2, we subtracted the Raman spectra of 4-ATP with the heterostructure SERS substrate from the spectrum of the heterostructure SERS substrate on its own. (B) Plots showing how the Raman profile from 4-ATP varies in the presence of the 0D-GNP surface and without any surface. (C) Plots showing how the Raman profile from 4-ATP varies in the presence of a heterostructure and GNP surface. (D) Plots showing how the Raman profile from 4-ATP varies with concentration in the presence of the heterostructure. The inserted plot shows how log(intensity at 1078 cm−1) varies with log(concentration of 4-ATP). (E) Plots showing how the Raman profile from Rh-6G varies in the presence of the heterostructure and the GNP surface. (F) A plot showing how log(Raman sensitivity) for 4-ATP varies between heterostructures made in different batches. (G) FDTD simulation data showing the electric field enhancement square (|E|2) profiles for a 0D-GNP assembly containing four nanoparticles.
Fig. 3(A) The Raman spectra from the multidrug resistant strain of Salmonella DT104 and the normal strain of Salmonella Typhi on the heterostructure surface. To remove the Eg and A1g band contributions from WS2, we subtracted the Raman spectra of the pathogens with the heterostructure SERS substrate from the spectrum for the heterostructure SERS substrate on its own. (B) Plots showing how the Raman spectrum from the multidrug resistant strain of Salmonella DT104 varies with concentration (CFU mL−1). (C) Plots showing how the Raman spectrum from the normal strain of Salmonella Typhi varies with concentration (CFU mL−1). (D) Plots showing how the time dependent Raman spectra from the normal strain of Salmonella Typhi vary during Augmentin antibiotic treatment. We used 1000 CFU mL−1Salmonella Typhi bacteria for this experiment. (E) A plot showing how the time dependent Raman spectra from the multidrug resistant Salmonella DT104 vary during Augmentin antibiotic treatment We used 1000 CFU mL−1Salmonella DT104 bacteria for this experiment. (F) A SEM image showing that the bacterial cell wall gets damaged when the normal strain of Salmonella Typhi was treated with the Augmentin antibiotic. (G) A SEM image of the Salmonella DT104 bacteria after antibiotic treatment. It shows that the bacterial cell wall remains intact when multidrug resistant Salmonella DT104 was treated with the Augmentin antibiotic. (H) Plots indicating the percentages of live bacteria for Salmonella DT104 and Salmonella Typhi during treatment with the Augmentin antibiotic. We used 1000 CFU mL−1 bacteria for this experiment. (I) A plot showing how the SERS intensity at 1140 cm−1 decreases as the number of live bacteria decreases during treatment with the Augmentin antibiotic. We reported the ratio of SERS intensity at 1140 cm−1 before and after treatment. We used 1000 CFU mL−1Salmonella Typhi bacteria for this experiment. (J) Plots showing the relative cellular ATP leakage from Salmonella DT104 and Salmonella Typhi after treating with the Augmentin antibiotic.